Copyright: ©Author(s) 2026.
World J Clin Pediatr. Jun 9, 2026; 15(2): 117274
Published online Jun 9, 2026. doi: 10.5409/wjcp.v15.i2.117274
Published online Jun 9, 2026. doi: 10.5409/wjcp.v15.i2.117274
Table 7 The different biotic interventions to modulate the gut-brain axis
| Intervention type | Definition/source | Key mechanisms on gut-brain axis | Examples | Observed effects (general and specific) |
| Probiotics | Live microorganisms (e.g., bacteria or yeast) that, when administered in adequate amounts, confer a health benefit on the host | Directly modulate the gut microbial composition. They produce short-chain fatty acids like butyrate, which can cross the blood-brain barrier. They also modulate the production of neurotransmitters (e.g., gamma-aminobutyric acid, serotonin) and reduce systemic inflammation | Bacteria: Lactobacillus species (Lactobacillus rhamnosus, Lactobacillus acidophilus), Bifidobacterium species (Bifidobacterium longum, Bifidobacterium infantis) | General: Improved mood, reduced anxiety, improved gut health (e.g., reduced IBS symptoms). Specific: Probiotics with Fructo-oligosaccharide in children with autism spectrum disorder were found to improve autism-related symptoms, increase beneficial bacteria, and reduce the hyper-serotonergic state and dopamine metabolism disorder |
| Prebiotics | Selectively fermented ingredients (often non-digestible fibers) that nourish and result in specific changes in the composition and/or activity of the beneficial gastrointestinal microbiota | Indirectly influences the brain by serving as food for beneficial gut bacteria, thereby increasing short-chain fatty acid production (especially butyrate). They enhance gut barrier function and indirectly influence the nervous system by reducing inflammation and modulating short-chain fatty acid signaling | Fibers: Fructans (inulin, Fructo-oligosaccharides), Galacto-oligosaccharides | General: Selective growth of beneficial bacteria (Bifidobacteria, Lactobacillus), enhanced mineral absorption, reduced constipation. Specific: Fructo-oligosaccharide used in combination with probiotics in children with autism spectrum disorder was associated with improved symptoms and beneficial gut change |
| Synbiotics | A product containing both Probiotics (live microorganisms) and Prebiotics (their selectively utilized food substrate) in a combined form | Combines the direct seeding and modulating effects of probiotics with the selective nourishment and short-chain fatty acid-boosting effects of prebiotics, potentially offering a synergistic effect on the gut-brain axis | Commercial blends containing strains such as Bifidobacterium and a fiber source such as Fructo-oligosaccharides or inulin | Effects are similar to or enhanced versions of those observed with single-agent interventions, often formulated to maximize the survival and activity of the probiotic strain |
- Citation: Elbeltagi YM, Abd Rab El Rasool AO, Elkashlan AM, Al-Beltagi M. Medical treatment of autism spectrum disorder in children: Current evidence, controversies, and clinical challenges. World J Clin Pediatr 2026; 15(2): 117274
- URL: https://www.wjgnet.com/2219-2808/full/v15/i2/117274.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v15.i2.117274